Novo Nordisk (NVO) and Pfizer (PFE) stand out as the cheapest large-cap healthcare names in 2026, trading at forward price-to-earnings multiples of 14x and 8x, respectively. Both companies currently grapple with significant headwinds—including drug pricing reforms and patent cliffs—but maintain strong free cash flow and upcoming data catalysts, according to data from 24/7 Wall St. … Read more
ON Semiconductor shares closed at US$90.65, reflecting a 25.5% decline over the past week and a 27.4% drop over the past month, according to Simply Wall St data. Despite this recent volatility, the stock maintains a 59.9% gain year-to-date. Investors are currently weighing the company’s valuation against shifting demand in the electric vehicle (EV), power … Read more
Robert Half (NYSE: RHI) is trading at approximately $32.76, a price that Simply Wall St’s Discounted Cash Flow model suggests is undervalued by 45.6% against an intrinsic value of $60.21. Although the stock rose 20.8% in the last month, it has seen a 13.7% decline over the past year as investors weigh recruitment demand against … Read more
APA Corporation reported a strong first-quarter 2026, with earnings reaching $489 million, or $1.38 per diluted share. This performance was driven by higher realized oil prices and disciplined expense management. The company’s production averaged 442,000 barrels of oil equivalent (BOE) per day during the period, highlighting the firm’s ability to maintain profitability through operational efficiency. … Read more
The Fortress Balance Sheet: Why Zero Debt is the Ultimate Dividend Safeguard In an era of fluctuating interest rates and unpredictable global markets, investors are increasingly hunting for one specific trait: certainty. When a company’s board decides to raise dividends, it isn’t just a gesture of goodwill; it is a signal of financial health. But … Read more
The Valuation Gap: Why the Market is Hesitant For investors scanning the Hong Kong auto sector, Chery Automobile (SEHK: 9973) presents a classic valuation puzzle. While the current share price sits at HK$28.82, a deeper dive into the fundamentals suggests a significant disconnect between market price and intrinsic value. Is Chery Automobile Fair Ratio Discounted … Read more
Why Wong Fong Industries’ Cash Flow Strength Signals Long-Term Resilience Wong Fong Industries Limited’s recent earnings report drew investor attention not just for its profit figures, but for the underlying quality of those earnings. The company reported an accrual ratio of -0.17 for the year to December 2025—a figure that immediately stands out in financial … Read more
Gilead Sciences: Is the Biotech Giant Undervalued? Investors are reassessing Gilead Sciences (GILD) after a strong performance, but is there still room for growth? Recent analysis suggests the stock may be significantly undervalued, presenting a potential opportunity for investors. The share price closed at $143.93, with year-to-date returns of 18.4% and a 26.0% increase over … Read more
Mondelez: Navigating Valuation Amidst Mixed Signals Mondelez International (MDLZ) is currently presenting a complex picture for investors. Recent performance shows a mixed backdrop, with a 4.7% return over the past week, but a 1.1% decline over the last year. Despite these fluctuations, the stock has demonstrated strong long-term growth, boasting returns of 14.8% year-to-date, 1.6% … Read more
Take-Two Interactive: Navigating a Complex Valuation Landscape Take-Two Interactive Software (NASDAQ:TTWO) has seen a recent 5.9% gain over the last seven days, but longer-term returns paint a mixed picture – a 13.0% decline over 30 days, a 15.9% decline year-to-date and a relatively flat 0.2% return over the past year. Despite these fluctuations, the stock … Read more